4.7 Article

Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort

Journal

ANTIVIRAL RESEARCH
Volume 117, Issue -, Pages 69-74

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.antiviral.2015.03.002

Keywords

Low-CD4 restoration; Mortality; AIDS; Non-AIDS-defining events; Non-AIDS-defining malignancies; Immunodeficiency; Clinical complications

Funding

  1. Instituto de Salud Carlos III through the Red Tematica de Investigacion Cooperativa en SIDA, Plan Nacional R + D + I [RD12/0017/0018]
  2. ISCIII-Subdireccion General de Evaluacion
  3. Fondo Europeo de Desarrollo Regional (FEDER)
  4. Fondo de Investigacion Sanitaria [FIS] [P11/02014]
  5. Spanish AIDS Research Network of Excellence [RIS] [RD12/0017/0029]
  6. Ministerio de Sanidad, Politica Social e Igualdad [EC11-520]
  7. Fundacion Progreso y Salud [PI-0081-2011]
  8. Fondo de Investigacion Sanitaria through Miguel Servet program [CP07/00240, CPII13/00037]
  9. Consejeria de Salud y Bienestar Social of Junta de Andalucia through Nicolas Monardes program [C-0010/13]

Ask authors/readers for more resources

The aim was to analyze clinical complications in HIV-infected subjects who persistently maintain low CD4 levels despite virological response to cART in the Spanish CoRIS cohort. The main inclusion criteria were CD4 counts <200 cells/mm(3) at cART-initiation and at least 2 years under cART achieving a viral load <500 copies/mL. Those patients with CD4 counts <250 cells/mm(3) 2 years after cART were classified as the Low-CD4 group, and clinical events were collected from this time-point. Poisson regression models were used to calculate incidence rate ratios of death, AIDS-defining events, serious non-AIDS-defining events (NAE) and of each specific NAE category (non-AIDS-defining malignancies (non-ADM), cardiovascular, kidney- and liver-related events). Of 9667 patients in the cohort, a total of 1128 met the criteria and 287 (25.4%) were classified in the Low-CD4 group. A higher risk of death (aIRR: 4.71; 95% CI: 1.88-11.82; p-value = 0.001) and of non-ADM were observed in this group (aIRR: 2.23; 95% CI: 1.07-4.63; p = 0.03). Our results stress the need to control accelerated aging in this population to counter their increased risk of non-AIDS-defining diseases, particularly cancer, and are consistent with the concept that clinical complications are potentially affected by genetics and lifestyle. (C) 2015 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available